Insta
Bharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus.
The World Health Organisation (WHO) on Tuesday (5 October) said that it will take a decision on granting Emergency Use Listing (EUL) to Bharat Biotech's Covaxin next week.
The WHO added that Bharat Biotech has been submitting data to it on a rolling basis and provided additional information at its request on 27 September.
"WHO experts are currently reviewing this info and if it addresses all questions raised, WHO assessment will be finalised next week," the global health body said.
Hyderabad-based Bharat Biotech had recently made a presentation of the safety and efficacy data on its vaccine to the strategic advisory group of experts on immunization (SAGE), an expert body that advises the WHO, reports Economic Times.